Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor
13 déc. 2024 09h45 HE
|
Curative Biotechnology, Inc.
Palm Beach Gardens, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel...
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
22 mars 2024 09h45 HE
|
Curative Biotechnology, Inc.
Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel...
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
08 janv. 2024 09h45 HE
|
Curative Biotechnology, Inc.
Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Curative...
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
06 juin 2023 09h50 HE
|
Curative Biotechnology, Inc.
Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
24 mai 2023 10h12 HE
|
Curative Biotechnology, Inc.
Topical Administration Capable of Delivering Metformin to Choroid, RPE, and Retina Boca Raton, FL, May 24, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or...
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study
05 janv. 2023 07h50 HE
|
Curative Biotechnology, Inc.
Boca Raton, FL, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange
27 sept. 2022 07h00 HE
|
Curative Biotechnology, Inc.
Boca Raton, FL, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments...
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors
16 juin 2022 09h50 HE
|
Curative Biotechnology, Inc.
Appointment of Independent Director Builds Upon Biotech Expertise Boca Raton, FL, June 16, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a...
Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors
12 mai 2022 09h30 HE
|
Curative Biotechnology, Inc.
Appointment of Independent Director Adds to Financial Expertise on Board Boca Raton, FL, May 12, 2022 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the...
Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration
03 mai 2022 09h30 HE
|
Curative Biotechnology, Inc.
National Eye Institute (NEI) to Collaborate with Curative Biotechnology under Cooperative Research and Development Agreement (CRADA) Boca Raton, FL, May 03, 2022 (GLOBE NEWSWIRE) -- Curative...